Biohaven Ltd. financial data

Symbol
BHVN on NYSE
Industry
Pharmaceutical Preparations
Location
215 Church Street, New Haven, CT
State of incorporation
Virgin Islands, British
Fiscal year end
December 31
Former names
Biohaven Research Ltd. (to 9/14/2022)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 387 % -27%
Debt-to-equity 41.7 % +46.2%
Return On Equity -225 % -105%
Return On Assets -159 % -85.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101M shares +26%
Common Stock, Shares, Outstanding 94.9M shares +38.8%
Entity Public Float 987M USD
Common Stock, Value, Issued 1.38B USD +123%
Weighted Average Number of Shares Outstanding, Basic 94.4M shares +38.1%
Weighted Average Number of Shares Outstanding, Diluted 94.4M shares +38.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 763M USD +103%
General and Administrative Expense 85.7M USD -28.7%
Costs and Expenses 849M USD +71.2%
Operating Income (Loss) -849M USD -71.2%
Nonoperating Income (Expense) 17.8M USD +280%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -805M USD -68.1%
Income Tax Expense (Benefit) -525K USD +96.3%
Net Income (Loss) Attributable to Parent -804M USD -73.2%
Earnings Per Share, Basic -9.42 USD/shares -30.3%
Earnings Per Share, Diluted -9.42 USD/shares -30.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.4M USD -24.4%
Marketable Securities, Current 294M USD +128%
Other Assets, Current 1.2M USD -94.8%
Assets, Current 441M USD +41.8%
Property, Plant and Equipment, Net 18.3M USD +3.44%
Operating Lease, Right-of-Use Asset 28.9M USD -10.6%
Intangible Assets, Net (Excluding Goodwill) 18.4M USD 0%
Goodwill 1.39M USD 0%
Other Assets, Noncurrent 32M USD -7.92%
Assets 511M USD +33.4%
Accounts Payable, Current 19.7M USD +108%
Employee-related Liabilities, Current 15.9M USD +13.6%
Accrued Liabilities, Current 63.5M USD +20.7%
Liabilities, Current 152M USD +145%
Operating Lease, Liability, Noncurrent 25.3M USD -10.5%
Other Liabilities, Noncurrent 4.59M USD +103%
Liabilities 195M USD +110%
Accumulated Other Comprehensive Income (Loss), Net of Tax 140K USD -11.4%
Retained Earnings (Accumulated Deficit) -1.16B USD -227%
Stockholders' Equity Attributable to Parent 316M USD +8.97%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 539M USD +1453%
Liabilities and Equity 511M USD +33.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -103M USD -32.2%
Net Cash Provided by (Used in) Financing Activities 3.42M USD -87.2%
Net Cash Provided by (Used in) Investing Activities 34M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 94.9M shares +38.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -65.2M USD -25.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 88M USD -30.1%
Deferred Tax Assets, Valuation Allowance 259M USD +20.1%
Operating Lease, Liability 30.9M USD -8.1%
Depreciation 3.87M USD +26.2%
Payments to Acquire Property, Plant, and Equipment 440K USD -40.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -804M USD -73.2%
Lessee, Operating Lease, Liability, to be Paid 39.8M USD -10.8%
Operating Lease, Liability, Current 3.68M USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.78M USD -4%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.02M USD +1.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.9M USD -18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.91M USD +3.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.2M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.51M USD -7.32%
Additional Paid in Capital 93M USD +263%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.45M USD -12.3%
Deferred Tax Assets, Net of Valuation Allowance 7.52M USD +1061%